These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Clinicoradiological comparative study of Aquaporin-4-IgG seropositive neuromyelitis optica spectrum disorder (NMOSD) and MOG antibody associated disease (MOGAD): A prospective observational study and review of literature. Nagireddy RBR, Kumar A, Singh VK, Prasad R, Pathak A, Chaurasia RN, Mishra VN, Joshi D. J Neuroimmunol; 2021 Dec 15; 361():577742. PubMed ID: 34655992 [Abstract] [Full Text] [Related]
8. Interleukin-6 Receptor Blockade in Treatment-Refractory MOG-IgG-Associated Disease and Neuromyelitis Optica Spectrum Disorders. Ringelstein M, Ayzenberg I, Lindenblatt G, Fischer K, Gahlen A, Novi G, Hayward-Könnecke H, Schippling S, Rommer PS, Kornek B, Zrzavy T, Biotti D, Ciron J, Audoin B, Berthele A, Giglhuber K, Zephir H, Kümpfel T, Berger R, Röther J, Häußler V, Stellmann JP, Whittam D, Jacob A, Kraemer M, Gueguen A, Deschamps R, Bayas A, Hümmert MW, Trebst C, Haarmann A, Jarius S, Wildemann B, Grothe M, Siebert N, Ruprecht K, Paul F, Collongues N, Marignier R, Levy M, Karenfort M, Deppe M, Albrecht P, Hellwig K, Gold R, Hartung HP, Meuth SG, Kleiter I, Aktas O, Neuromyelitis Optica Study Group (NEMOS). Neurol Neuroimmunol Neuroinflamm; 2022 Jan 15; 9(1):. PubMed ID: 34785575 [Abstract] [Full Text] [Related]
9. Myelin oligodendrocyte glycoprotein antibody-associated disease: an immunopathological study. Takai Y, Misu T, Kaneko K, Chihara N, Narikawa K, Tsuchida S, Nishida H, Komori T, Seki M, Komatsu T, Nakamagoe K, Ikeda T, Yoshida M, Takahashi T, Ono H, Nishiyama S, Kuroda H, Nakashima I, Suzuki H, Bradl M, Lassmann H, Fujihara K, Aoki M, Japan MOG-antibody Disease Consortium. Brain; 2020 May 01; 143(5):1431-1446. PubMed ID: 32412053 [Abstract] [Full Text] [Related]
10. Comparative analysis of clinical and imaging data between patients with myelin oligodendrocyte glycoprotein antibody disease and patients with aquaporin 4 antibody-positive neuromyelitis optica spectrum disorder. Xie H, Shao Y, Du J, Song Y, Li Y, Duan R, Yao Y, Gong Z, Teng J, Jia Y. J Neurol; 2022 Mar 01; 269(3):1641-1650. PubMed ID: 34383114 [Abstract] [Full Text] [Related]
18. Tumefactive Demyelination in MOG Ab-Associated Disease, Multiple Sclerosis, and AQP-4-IgG-Positive Neuromyelitis Optica Spectrum Disorder. Cacciaguerra L, Morris P, Tobin WO, Chen JJ, Banks SA, Elsbernd P, Redenbaugh V, Tillema JM, Montini F, Sechi E, Lopez-Chiriboga AS, Zalewski N, Guo Y, Rocca MA, Filippi M, Pittock SJ, Lucchinetti CF, Flanagan EP. Neurology; 2023 Mar 28; 100(13):e1418-e1432. PubMed ID: 36690455 [Abstract] [Full Text] [Related]
19. Comparative Analysis of T-Cell Responses to Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein in Inflammatory Demyelinating Central Nervous System Diseases. Hofer LS, Ramberger M, Gredler V, Pescoller AS, Rostásy K, Sospedra M, Hegen H, Berger T, Lutterotti A, Reindl M. Front Immunol; 2020 Mar 28; 11():1188. PubMed ID: 32625206 [Abstract] [Full Text] [Related]